IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 118
Titolo Data di pubblicazione Autore(i) File
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials 1-gen-2013 Ciliberto, Domenico; Botta, Cirino; Correale, Pierpaolo; Caraglia, Michele; Tassone, Pierfrancesco; Tagliaferri, P; Rossi, M
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease 1-gen-2013 Pitari Maria, Rita; Amodio, Nicola; Di Martino Maria, Teresa; Conforti, Francesco; Leone, Emanuela; Botta, Cirino; Paolino Francesco, Maria; Del Giudice, Teresa; Iuliano, Eleonora; Caraglia, Michele; Ferrarini, Manlio; Giordano, Antonio; Tassone, P; Tagliaferri, P; Rossi, M
Whole Body Magnetic Resonance and CT/PET in patients with multiple myeloma at staging and after treatment: personal experience in a longitudinal study 1-gen-2013 Cascini, Gl; Carmela, Falcone; Domenico, Console; Antonino, Restuccia; Rossi, Marco; Antonello, Parlati; Oscar, Tamburrini
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario 1-gen-2013 Amodio, N; Di Martino, Mt; Caracciolo, D; Tassone, P; Tagliaferri, P; Rossi, M
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 1-gen-2013 Leone, Emanuela; Morelli, Eugenio; Di Martino Maria, T.; Amodio, Nicola; Foresta, Umberto; Gulla, Annamaria; Neri, Antonino; Giordano, Antonio; Munshi Nikhil, C.; Anderson Kenneth, C.; Tassone, P; Tagliaferri, P; Rossi, M
Immunologic microenvironment and personalized treatment in multiple myeloma 1-gen-2013 Botta, C; Correale, P; Tassone, P; Tagliaferri, P; Rossi, M
Non Homologous End Joining As a New Prognostic Factor and Potential Target in Multiple Myeloma 1-gen-2014 Calimeri, T; Caracciolo, D; Samur, Mk; Amodio, N; Cea, M; Cagnetta, A; Fulciniti, M; Adamia, S; Rossi, M; Tai, Y-T; Morabito, F; Minvielle, S; Avet-Loiseau, H Li C; Lazaro, J-B; Anderson, Kc; Shammas, M; Tagliaferri, P; Tassone, P; Munshi, N
MiR-29b Counteracts Aberrant HDAC4 Expression and Enhances Vorinostat Activity in Multiple Myeloma 1-gen-2014 Amodio, N; Leotta, M; Gulla, Am; Raimondi, L; Morelli, E; Stamato, Ma; Calimeri, T; Di Martino, Mt; Rossi, M; Leone, E; Neri, A; Tagliaferri, P and Tassone P
MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches 1-gen-2014 Amodio, N; Di Martino, Mt; Tagliaferri, P; Cho, Wc; Tassone, P; Rossi, M
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 1-gen-2014 Di Martino, Maria Teresa; Gullà, Annamaria; Gallo Cantafio, Maria Eugenia; Altomare, Emanuela; Amodio, Nicola; Leone, Emanuela; Morelli, Eugenio; Lio, Santo Giovanni; Caracciolo, Daniele; Rossi, Marco; Frandsen, Niels M; Tagliaferri, Pierosandro; Tassone, Pierfrancesco
Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia 1-gen-2014 Rossi, M; Gentile, M; Toscano, R; Recchia, Ag; Bossio, S; Caruso, N; De Stefano, L; Granata, T; Pellicanò, M; Vigna, E; Tagliaferri, P; Morabito, F; Tassone, P
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 1-gen-2014 Di Martino, Mt; Gullà, A; Gallo Cantafio, Me; Altomare, E; Amodio, N; Leone, E; Morelli, E; Lio, Sg; Caracciolo, D; Frandsen, Nm; Tagliaferri, P; Tassone, P; Rossi, M
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 1-gen-2014 Leporini, Christian; Patane, Marinella; Saullo, Francesca; Rende, Pierandrea; Toscano, Rosa; Lucia, Maria; DE SARRO, Giovambattista; Russo, E; Donato Di Paola, E; Gallelli, L; Rossi, M
Targeting Aberrant Non-Homologous End Joining in Multiple Myeloma: Role of the Classical and Alternative Pathways in Genomic Instability 1-gen-2014 Calimeri, T; Caracciolo, D; Amodio, N; Samur, Mk; Leotta, M; Fulciniti, M; Rossi, M; Minvielle, S; Avet-Loiseau, H; Tagliaferri, P; Shammas, M; Anderson, Kc; Tassone, P; and Munshi, Nc
Selective targeting of IRF4 by sytnthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo 1-gen-2015 Morelli, E; Leone, E; Gallo Cantafio, Me; Di Martino, Mt; Amodio, N; Biamonte, L; Gullà, A; Foresta, U; Pitari, Mr; Botta, C; Rossi, M; Tagliaferri, P and Tassone P
Multiple myeloma-related bone disease: state-of-art and future treatments 1-gen-2015 Rossi, M; Teresa, Calimeri; Pierosandro Tagliaferri, & Pierfrancesco Tassone
New Approaches to Predict Outcome and Personalize Therapy in Multiple Myeloma: from microRNAs to Integrated Genomics 1-gen-2015 Rossi, M; Maria Teresa Di Martino, ; Guzzi, PIETRO HIRAM; Pierosandro Tagliaferri and Pierfrancesco Tassone,
Multiple Myeloma Cells downregulatemiR-29b in dendritic cells to promote a tumor permissive inflammatory microenvironment and immune escape 1-gen-2015 Botta, C; Cucè, M; Pitari, Mr; Caracciolo, D; Fiorillo, L; Gullà, A; Morelli, E; Del Giudice, T; Gallo Cantafio, Me; Amodio, N; Di Martino, Mt; Correale, P; Rossi, M; Tagliaferri, P and Tassone P
Targeting miR-21 in bone marrow stromal cells restores RANKL/OPG ratio within multiple myeloma microenvironment 1-gen-2015 Pitari, Mr; Rossi, M; Amodio, N; Botta, C; Morelli, E; Federico, C; Gullà, A; Caracciolo, D; Di Martino, Mt; Tagliaferri, P; and Tassone, P
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts 1-gen-2015 Pitari, Mr; Amodio, N; Botta, C; Morelli, E; Federico, C; Gullà, A; Caracciolo, D; Di Martino, Mt; Arbitrio, M; Giordano, A; Tassone, P; Tagliaferri, P; Rossi, M
Mostrati risultati da 41 a 60 di 118
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile